Schroeder Comments on Future of Nondisclosure Agreements in Wake of Weinstein Scandal
October 25, 2017
Law360
Partner Donald Schroeder is quoted in a Law360 article, “Weinstein Scandal Not Enough To Kill Confidentiality Pacts,” about the potential impact of the Harvey Weinstein sexual misconduct scandal on the use of nondisclosure provisions in employment contracts.
Schroeder noted that nondisclosure provisions in employment agreements don’t restrict an employee’s ability to report anything he or she saw or experienced in the workplace and don’t take away an employer’s duty to investigate such claims. He also said that employees are free to breach such agreements, with the employer’s only real recourse being to pursue liquidated damages.
“Whatever an employment agreement says, it won’t impact an individual’s ability to report sexual harassment either through human resources or through [a company’s] code of conduct,” he said.
While he acknowledged that public pressure could subject such agreements to closer scrutiny, Schroeder said attention is more likely to be focused on “making sure companies have an open-door policy” for reporting harassment and having various avenues for employees to report misconduct.
Schroeder noted that nondisclosure provisions in employment agreements don’t restrict an employee’s ability to report anything he or she saw or experienced in the workplace and don’t take away an employer’s duty to investigate such claims. He also said that employees are free to breach such agreements, with the employer’s only real recourse being to pursue liquidated damages.
“Whatever an employment agreement says, it won’t impact an individual’s ability to report sexual harassment either through human resources or through [a company’s] code of conduct,” he said.
While he acknowledged that public pressure could subject such agreements to closer scrutiny, Schroeder said attention is more likely to be focused on “making sure companies have an open-door policy” for reporting harassment and having various avenues for employees to report misconduct.
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 6, 2025
In the News
Louis Lehot Comments on Crypto Company IPO – 'Definitely a home run'
Foley & Lardner LLP partner Louis Lehot commented on the initial public offering of stablecoin issuer Circle in the Law360 article, "Circle's Smash IPO Could Pave Way For More Crypto Listings."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."